網(wǎng)站介紹 關(guān)于我們 聯(lián)系方式 友情鏈接 廣告業(yè)務(wù) 幫助信息
1998-2022 ChinaKaoyan.com Network Studio. All Rights Reserved. 滬ICP備12018245號(hào)
1. 基本情況:
魏夢(mèng)雪博士,副教授,碩士生導(dǎo)師(有機(jī)化學(xué))。第三批“寧夏青年科技人才托舉工程”入選者(2018.9)。
2009年9─2013年6,蘭州大學(xué)博士(有機(jī)合成化學(xué),導(dǎo)師:樊春安教授);
2013年8月─至今,在寧夏大學(xué)化學(xué)化工學(xué)院從事教學(xué)、科研工作。
研究方向:1) 不對(duì)稱催化方法學(xué)及其導(dǎo)向的天然產(chǎn)物合成;2) 功能有機(jī)藥物分子合成及生物活性研究。
通訊地址:寧夏銀川市西夏區(qū)賀蘭山西路539號(hào)寧夏大學(xué)化學(xué)化工學(xué)院(郵編750021)
E-mail:weimengxue@nxu.edu.cn
2. 科研成果及主要論著:
近5年在天然產(chǎn)物不對(duì)稱全合成、手性藥物合成及生物活性研究領(lǐng)域開展研究工作,發(fā)表學(xué)術(shù)論文20篇,其中被Eur. J. Med.Chem.; Org. Lett.; Chem. Asian J.等國(guó)際高水平期刊收錄的SCI論文12篇,累計(jì)IF> 30;授權(quán)國(guó)家發(fā)明專利1項(xiàng)。
科研項(xiàng)目:
1) 主持寧夏青年科技人才托舉工程項(xiàng)目1項(xiàng)(2018.07─2021.09);
2) 主持寧夏自然科學(xué)基金(重點(diǎn))項(xiàng)目1項(xiàng)(2017.8─2019.8);
3) 主持寧夏大學(xué)服務(wù)地方項(xiàng)目一項(xiàng)(2018.1─2020.12);
4) 參與(第一合作者)國(guó)家自然科學(xué)基金項(xiàng)目1項(xiàng)(2016.1─2019.12);
5) 主持完成國(guó)家自然科學(xué)基金項(xiàng)目1項(xiàng)(2015.1─2018.12);
獲獎(jiǎng)及榮譽(yù):
1) 指導(dǎo)2018年自治區(qū)級(jí)大學(xué)生創(chuàng)新創(chuàng)業(yè)訓(xùn)練計(jì)劃項(xiàng)目獲優(yōu)秀獎(jiǎng)(2019.1);
2) 指導(dǎo)2017年國(guó)家級(jí)大學(xué)生創(chuàng)新創(chuàng)業(yè)訓(xùn)練計(jì)劃項(xiàng)目獲優(yōu)秀獎(jiǎng)(2018.4);
3) 寧夏大學(xué)2016屆本科畢業(yè)論文優(yōu)秀指導(dǎo)教師獎(jiǎng)(2016.7);
4) 第十三屆寧夏自然科學(xué)優(yōu)秀學(xué)術(shù)論文二等獎(jiǎng)(2015.12);
5) 第十屆寧夏自然科學(xué)優(yōu)秀學(xué)術(shù)論文一等獎(jiǎng)(2009.10)。
代表論文:
[1] Jia-YingYu, Xue-Qiang Li, Meng-Xue Wei*, Synthesis and biological activities ofartemisinin-piperazine-dithiocarbamate derivatives. Eur. J. Med.Chem., 2019, 169, 21-28. (SCI, 藥物化學(xué)1區(qū), Top期刊, IF = 4.816)
[2] Meng-XueWei*,1,Jiao Zhang1, Fu-Li Ma, Ming Li, Jia-Ying Yu, Wei Luo, Xue-QiangLi**, Synthesis and biological activities of dithiocarbamates containing 2(5H)-furanone-piperazine.Eur.J. Med. Chem., 2018, 155, 165-170. (SCI, 藥物化學(xué)1區(qū), Top期刊, IF = 4.816)
[3] FuliMa, Jiao Zhang, Ming Li, Jiaying Yu, Wei Luo, Xueqiang Li*, Mengxue Wei*,Synthesis of Novel Matrine Derivatives Containing Furanone Skeleton andPreliminary Evaluation of Their Anticancer Activity. Chin. J. Org. Chem., 2018,38 (10), 2633-2638. (SCI, IF = 1.392)
[4] MengxueWei,Jian Xu, He Zhang, Xueqiang Li*, Synthesis and Anti-tumor Effect of ArtemisoneDerivatives. Chin. J. Org. Chem., 2015, 35 (5), 1097-1103. (SCI, IF =1.392)
[5] MengxueWei,XiaohuiGao, He Zhang, Xueqiang* Li, Synthesis of New Chiralγ-Alkoxy-2(5H)-furanone-piperazine-sulfonamide Compounds and PreliminaryEvaluation of in Vitro Anticancer Activity. Chin. J. Org. Chem., 2015,35 (2), 439-445. (SCI, IF = 1.392)
[6] JianXU, Mengxue WEI, Guoming LI, Xueqiang LI*, Synthesis and Anti-tumorActivities of Novel Artemisone-piperazine-sulfonamide Derivatives. Chem. J.Chin. U., 2015, 36 (5), 919-926. (SCI)
[7] CouxiChen, Mengxue Wei, Xueqiang Li *, Tiancai Li, Xuezhang Zhou, RationalSynthesis and Preliminary Anti-cancer Activities of 18β-Glycyrrhetinic AcidDerivatives Containing Pyridinecarboxamide. Chin. J. Org. Chem., 2015,35 (4), 835-842. (SCI, IF = 1.392)
[8] Meng-XueWei,Cheng-Tao Wang, Ji-Yuan Du, Hu Qu, Pei-Rong Yin, Xu Bao, Xiao-Yan Ma, Xian-HeZhao, Guo-Biao Zhang, and Chun-An Fan*, EnantioselectiveSynthesis of Amaryllidaceae Alkaloids (+)-Vittatine, (+)-epi-Vittatine and (+)-Buphanisine.Chem.Asian J., 2013, 8 (9), 1966-1971. (SCI, 2區(qū), IF = 4.083)
[9] Meng-XueWei,Xiao-HuiGao, Tian-Cai Li, Chun-An Fan*, Xue-Qiang Li*, Transalkylation of N-methyltertiary amines with 3,4-dibromobutenolides. Chin. Chem. Lett., 2013, 24(9), 837-839. (SCI, IF = 2.631)
[10]JingLi, Guo-Liang Liu, Xian-He Zhao, Ji-Yuan Du, Hu Qu, Wen-Dao Chu, Ming Ding,Cong-Yang Jin, Meng-Xue Wei, and Chun-An Fan*, Formal Synthesis of(±)-Morphine. Chem. Asian J., 2013, 8 (6), 1105-1109. (SCI, 2區(qū), IF = 4.083)
[11]Guo-BiaoZhang, Fang-Xin Wang, Ji-Yuan Du, Hu Qu, Xiao-Yan Ma, Meng-Xue Wei,Cheng-Tao Wang, Qiong Li, and Chun-An Fan*, Towards the Total Synthesis ofPalhinine A: Expedient Assembly of Multifunctionalized Isotwistane Ring Systemwith Contiguous Quaternary Stereocenters. Org. Lett., 2012, 14 (14),3696-3699. (SCI, 1區(qū), Top期刊, IF = 6.492)
[12]Meng-XueWei,Lei Feng, Xue-Qiang Li*, Xue-ZhangZhou, Zhi-Hui Shao**,Synthesis of new chiral 2,5-disubstituted 1,3,4-thiadiazoles possessingγ-butenolide moiety and preliminary evaluation of in vitro anticancer activity.Eur.J. Med. Chem., 2009, 44 (8), 3340-3344.(SCI,藥物化學(xué)1區(qū), Top期刊, IF = 4.816)
來源未注明“中國(guó)考研網(wǎng)”的資訊、文章等均為轉(zhuǎn)載,本網(wǎng)站轉(zhuǎn)載出于傳遞更多信息之目的,并不意味著贊同其觀點(diǎn)或證實(shí)其內(nèi)容的真實(shí)性,如涉及版權(quán)問題,請(qǐng)聯(lián)系本站管理員予以更改或刪除。如其他媒體、網(wǎng)站或個(gè)人從本網(wǎng)站下載使用,必須保留本網(wǎng)站注明的"稿件來源",并自負(fù)版權(quán)等法律責(zé)任。
來源注明“中國(guó)考研網(wǎng)”的文章,若需轉(zhuǎn)載請(qǐng)聯(lián)系管理員獲得相應(yīng)許可。
聯(lián)系方式:chinakaoyankefu@163.com
掃碼關(guān)注
了解考研最新消息
網(wǎng)站介紹 關(guān)于我們 聯(lián)系方式 友情鏈接 廣告業(yè)務(wù) 幫助信息
1998-2022 ChinaKaoyan.com Network Studio. All Rights Reserved. 滬ICP備12018245號(hào)